Literature DB >> 12021345

Restriction of measles virus RNA synthesis by a mouse host cell line: trans-complementation by polymerase components or a human cellular factor(s).

Séverine Vincent1, Isabelle Tigaud, Henriette Schneider, Christian J Buchholz, Yusuke Yanagi, Denis Gerlier.   

Abstract

The mouse epithelial MODE-K cell line expressing human CD46 or CD150 cellular receptors was found to be nonpermissive for measles virus (MV) replication. The virus binding and membrane fusion steps were unimpaired, but only very limited amounts of virus protein and RNA synthesized were detected after the infection. In a minigenome chloramphenicol acetyltransferase assay, MODE-K cells were as able as the permissive HeLa cells in supporting MV polymerase activity. The restriction phenotype of MODE-K cells could be alleviated by providing, in trans, either N-P-L or N-P functional protein complexes but not by P-L complexes or individual N, P, and L proteins. Several human x mouse (HeLa x MODE-K) somatic hybrid clones expressing human CD46 were isolated and found to be either nonpermissive or permissive according to their human chromosomal contents. The MV-restricted phenotype exhibited by the MODE-K cell line suggests that a cellular factor(s) can control MV transcription, possibly by stabilizing the incoming virus polymerase templates.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12021345      PMCID: PMC136230          DOI: 10.1128/jvi.76.12.6121-6130.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  Measles virus structural components are enriched into lipid raft microdomains: a potential cellular location for virus assembly.

Authors:  S N Manié; S de Breyne; S Debreyne; S Vincent; D Gerlier
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Octamerization enables soluble CD46 receptor to neutralize measles virus in vitro and in vivo.

Authors:  D Christiansen; P Devaux; B Réveil; A Evlashev; B Horvat; J Lamy; C Rabourdin-Combe; J H Cohen; D Gerlier
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

3.  Evasion of host defenses by measles virus: wild-type measles virus infection interferes with induction of Alpha/Beta interferon production.

Authors:  D Naniche; A Yeh; D Eto; M Manchester; R M Friedman; M B Oldstone
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

4.  Cooperative binding of multimeric phosphoprotein (P) of vesicular stomatitis virus to polymerase (L) and template: pathways of assembly.

Authors:  Y Gao; J Lenard
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

5.  Enhanced measles virus cDNA rescue and gene expression after heat shock.

Authors:  C L Parks; R A Lerch; P Walpita; M S Sidhu; S A Udem
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

6.  SLAM (CDw150) is a cellular receptor for measles virus.

Authors:  H Tatsuo; N Ono; K Tanaka; Y Yanagi
Journal:  Nature       Date:  2000-08-24       Impact factor: 49.962

7.  Infection of chicken embryonic fibroblasts by measles virus: adaptation at the virus entry level.

Authors:  C Escoffier; D Gerlier
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

8.  A functional measles virus replication and transcription machinery encoded by the vaccinia virus genome.

Authors:  P M Howley; B Lafont; D Spehner; K Kaelin; M A Billeter; R Drillien
Journal:  J Virol Methods       Date:  1999-04       Impact factor: 2.014

9.  Inefficient measles virus budding in murine L.CD46 fibroblasts.

Authors:  S Vincent; D Spehner; S Manié; R Delorme; R Drillien; D Gerlier
Journal:  Virology       Date:  1999-12-20       Impact factor: 3.616

10.  Measles virus attenuation associated with transcriptional impediment and a few amino acid changes in the polymerase and accessory proteins.

Authors:  M Takeda; A Kato; F Kobune; H Sakata; Y Li; T Shioda; Y Sakai; M Asakawa; Y Nagai
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

View more
  12 in total

1.  Virus-driven conditional expression of an interferon antagonist as a tool to circumvent host restriction.

Authors:  Denis Gerlier
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-10       Impact factor: 11.205

2.  Dynamics of viral RNA synthesis during measles virus infection.

Authors:  Sébastien Plumet; W Paul Duprex; Denis Gerlier
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

3.  Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activation.

Authors:  Rūta Veinalde; Christian Grossardt; Laura Hartmann; Marie-Claude Bourgeois-Daigneault; John C Bell; Dirk Jäger; Christof von Kalle; Guy Ungerechts; Christine E Engeland
Journal:  Oncoimmunology       Date:  2017-01-31       Impact factor: 8.110

4.  Inhibition of ubiquitination and stabilization of human ubiquitin E3 ligase PIRH2 by measles virus phosphoprotein.

Authors:  Mingzhou Chen; Jean-Claude Cortay; Ian R Logan; Vasileia Sapountzi; Craig N Robson; Denis Gerlier
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

5.  Expression of the Sendai (murine parainfluenza) virus C protein alleviates restriction of measles virus growth in mouse cells.

Authors:  Masaharu Iwasaki; Yusuke Yanagi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-06       Impact factor: 11.205

6.  Immunovirotherapy with measles virus strains in combination with anti-PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment.

Authors:  Jayson Hardcastle; Lisa Mills; Courtney S Malo; Fang Jin; Cheyne Kurokawa; Hirosha Geekiyanage; Mark Schroeder; Jann Sarkaria; Aaron J Johnson; Evanthia Galanis
Journal:  Neuro Oncol       Date:  2017-04-01       Impact factor: 12.300

7.  Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model.

Authors:  Emily K Mader; Yoshihiro Maeyama; Yi Lin; Greg W Butler; Holly M Russell; Evanthia Galanis; Stephen J Russell; Allan B Dietz; Kah-Whye Peng
Journal:  Clin Cancer Res       Date:  2009-11-24       Impact factor: 12.531

8.  Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamide.

Authors:  R M Myers; S M Greiner; M E Harvey; G Griesmann; M J Kuffel; S A Buhrow; J M Reid; M Federspiel; M M Ames; D Dingli; K Schweikart; A Welch; A Dispenzieri; K-W Peng; S J Russell
Journal:  Clin Pharmacol Ther       Date:  2007-10-31       Impact factor: 6.875

9.  The intrinsically disordered C-terminal domain of the measles virus nucleoprotein interacts with the C-terminal domain of the phosphoprotein via two distinct sites and remains predominantly unfolded.

Authors:  Jean-Marie Bourhis; Véronique Receveur-Bréchot; Michael Oglesbee; Xinsheng Zhang; Matthew Buccellato; Hervé Darbon; Bruno Canard; Stéphanie Finet; Sonia Longhi
Journal:  Protein Sci       Date:  2005-08       Impact factor: 6.725

10.  The interaction between the measles virus nucleoprotein and the Interferon Regulator Factor 3 relies on a specific cellular environment.

Authors:  Matteo Colombo; Jean-Marie Bourhis; Celia Chamontin; Carine Soriano; Stéphanie Villet; Stéphanie Costanzo; Marie Couturier; Valérie Belle; André Fournel; Hervé Darbon; Denis Gerlier; Sonia Longhi
Journal:  Virol J       Date:  2009-05-15       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.